Table of Contents 1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Overview 1.1 Product Overview and Scope of Chronic Obstructive Pulmonary Disease (COPD) Drugs 1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Type 1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type (2014-2026) 1.2.2 The Market Profile of anticholinergic 1.2.3 The Market Profile of oral corticosteroid 1.2.4 The Market Profile of beta2-agonists 1.2.5 The Market Profile of phosphodiesterase-4 (PDE4) inhibitors 1.2.6 The Market Profile of others 1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Segment by Application 1.3.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026) 1.3.2 The Market Profile of lung functional test 1.3.3 The Market Profile of chest x-ray test 1.3.4 The Market Profile of CT scan 1.3.5 The Market Profile of others 1.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market by Region (2014-2026) 1.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) Comparison by Region (2014-2026) 1.4.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.1 Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.2 UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.3 France Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.4 Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.5 Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.6 Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.3.7 Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.1 Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.2 Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.3 Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.4 Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.5 Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.7.6 Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.8.1 Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.8.2 Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.8.3 Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.1 Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.2 United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.3 Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.4 Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.5 South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.4.9.6 Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Status and Prospect (2014-2026) 1.5 Global Market Size (Value) of Chronic Obstructive Pulmonary Disease (COPD) Drugs (2014-2026) 1.5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Status and Outlook (2014-2026) 1.5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026) 2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Landscape by Player 2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Share by Player (2014-2019) 2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Player (2014-2019) 2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Average Price by Player (2014-2019) 2.4 Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution, Sales Area and Product Type by Player 2.5 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Competitive Situation and Trends 2.5.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Concentration Rate 2.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Share of Top 3 and Top 6 Players 2.5.3 Mergers & Acquisitions, Expansion 3 Players Profiles 3.1 Gilead Sciences 3.1.1 Gilead Sciences Basic Information, Manufacturing Base, Sales Area and Competitors 3.1.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.1.3 Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.1.4 Gilead Sciences Business Overview 3.2 Novartis 3.2.1 Novartis Basic Information, Manufacturing Base, Sales Area and Competitors 3.2.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.2.3 Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.2.4 Novartis Business Overview 3.3 Ario Pharma 3.3.1 Ario Pharma Basic Information, Manufacturing Base, Sales Area and Competitors 3.3.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.3.3 Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.3.4 Ario Pharma Business Overview 3.4 Mylan 3.4.1 Mylan Basic Information, Manufacturing Base, Sales Area and Competitors 3.4.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.4.3 Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.4.4 Mylan Business Overview 3.5 F. Hoffmann-La Roche 3.5.1 F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Competitors 3.5.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.5.3 F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.5.4 F. Hoffmann-La Roche Business Overview 3.6 Asmacure 3.6.1 Asmacure Basic Information, Manufacturing Base, Sales Area and Competitors 3.6.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.6.3 Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.6.4 Asmacure Business Overview 3.7 Pearl Therapeutics 3.7.1 Pearl Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors 3.7.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.7.3 Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.7.4 Pearl Therapeutics Business Overview 3.8 Prosonix 3.8.1 Prosonix Basic Information, Manufacturing Base, Sales Area and Competitors 3.8.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.8.3 Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.8.4 Prosonix Business Overview 3.9 Merck 3.9.1 Merck Basic Information, Manufacturing Base, Sales Area and Competitors 3.9.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.9.3 Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.9.4 Merck Business Overview 3.10 Almirall 3.10.1 Almirall Basic Information, Manufacturing Base, Sales Area and Competitors 3.10.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.10.3 Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.10.4 Almirall Business Overview 3.11 Cytokinetics 3.11.1 Cytokinetics Basic Information, Manufacturing Base, Sales Area and Competitors 3.11.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.11.3 Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.11.4 Cytokinetics Business Overview 3.12 ZAI Lab 3.12.1 ZAI Lab Basic Information, Manufacturing Base, Sales Area and Competitors 3.12.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.12.3 ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.12.4 ZAI Lab Business Overview 3.13 AstraZeneca 3.13.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors 3.13.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.13.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.13.4 AstraZeneca Business Overview 3.14 Aquinox Pharmaceuticals 3.14.1 Aquinox Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors 3.14.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.14.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.14.4 Aquinox Pharmaceuticals Business Overview 3.15 Palobiofarma 3.15.1 Palobiofarma Basic Information, Manufacturing Base, Sales Area and Competitors 3.15.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.15.3 Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.15.4 Palobiofarma Business Overview 3.16 Ache Laboratorios Farmaceuticos 3.16.1 Ache Laboratorios Farmaceuticos Basic Information, Manufacturing Base, Sales Area and Competitors 3.16.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.16.3 Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.16.4 Ache Laboratorios Farmaceuticos Business Overview 3.17 Invion 3.17.1 Invion Basic Information, Manufacturing Base, Sales Area and Competitors 3.17.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.17.3 Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.17.4 Invion Business Overview 3.18 Chiesi Farmaceutici 3.18.1 Chiesi Farmaceutici Basic Information, Manufacturing Base, Sales Area and Competitors 3.18.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.18.3 Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.18.4 Chiesi Farmaceutici Business Overview 3.19 Boehringer Ingelheim 3.19.1 Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Competitors 3.19.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.19.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.19.4 Boehringer Ingelheim Business Overview 3.20 Pharmaxis 3.20.1 Pharmaxis Basic Information, Manufacturing Base, Sales Area and Competitors 3.20.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.20.3 Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.20.4 Pharmaxis Business Overview 3.21 Innoviva 3.21.1 Innoviva Basic Information, Manufacturing Base, Sales Area and Competitors 3.21.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.21.3 Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.21.4 Innoviva Business Overview 3.22 Orion Corporation 3.22.1 Orion Corporation Basic Information, Manufacturing Base, Sales Area and Competitors 3.22.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.22.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.22.4 Orion Corporation Business Overview 3.23 BioMarck Pharmaceuticals 3.23.1 BioMarck Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors 3.23.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.23.3 BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.23.4 BioMarck Pharmaceuticals Business Overview 3.24 Astellas Pharma 3.24.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors 3.24.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.24.3 Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.24.4 Astellas Pharma Business Overview 3.25 MediciNova 3.25.1 MediciNova Basic Information, Manufacturing Base, Sales Area and Competitors 3.25.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.25.3 MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.25.4 MediciNova Business Overview 3.26 Mereo BioPharma 3.26.1 Mereo BioPharma Basic Information, Manufacturing Base, Sales Area and Competitors 3.26.2 Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Profiles, Application and Specification 3.26.3 Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Performance (2014-2019) 3.26.4 Mereo BioPharma Business Overview 4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue (Value), Price Trend by Type 4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Type (2014-2019) 4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Market Share by Type (2014-2019) 4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019) 4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate by Type (2014-2019) 4.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019) 4.4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019) 4.4.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-agonists (2014-2019) 4.4.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of phosphodiesterase-4 (PDE4) inhibitors (2014-2019) 4.4.5 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of others (2014-2019) 5 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Analysis by Application 5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption and Market Share by Application (2014-2019) 5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate by Application (2014-2019) 5.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of lung functional test (2014-2019) 5.2.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of chest x-ray test (2014-2019) 5.2.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of CT scan (2014-2019) 5.2.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Growth Rate of others (2014-2019) 6 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import by Region (2014-2019) 6.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Region (2014-2019) 6.2 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.4 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.5 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.6 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.7 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.8 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 6.9 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) 7 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue (Value) by Region (2014-2019) 7.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Market Share by Region (2014-2019) 7.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue (Value) and Market Share by Region (2014-2019) 7.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.4 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.5 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.6 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.7 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.8 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.9 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.10 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 7.11 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) 8 Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Analysis 8.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Key Raw Materials Analysis 8.1.1 Key Raw Materials Introduction 8.1.2 Price Trend of Key Raw Materials 8.1.3 Key Suppliers of Raw Materials 8.1.4 Market Concentration Rate of Raw Materials 8.2 Manufacturing Cost Analysis 8.2.1 Labor Cost Analysis 8.2.2 Manufacturing Cost Structure Analysis 8.3 Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs 9 Industrial Chain, Sourcing Strategy and Downstream Buyers 9.1 Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis 9.2 Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Players in 2018 9.3 Downstream Buyers 10 Market Dynamics 10.1 Drivers 10.2 Restraints 10.3 Opportunities 10.3.1 Advances in Innovation and Technology for Chronic Obstructive Pulmonary Disease (COPD) Drugs 10.3.2 Increased Demand in Emerging Markets 10.4 Challenges 10.4.1 The Performance of Alternative Product Type is Getting Better and Better 10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices 10.5 Porter’s Five Forces Analysis 10.5.1 Threat of New Entrants 10.5.2 Threat of Substitutes 10.5.3 Bargaining Power of Suppliers 10.5.4 Bargaining Power of Buyers 10.5.5 Intensity of Competitive Rivalry 11 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Forecast (2019-2026) 11.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue Forecast (2019-2026) 11.1.1 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Growth Rate Forecast (2019-2026) 11.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2019-2026) 11.1.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price and Trend Forecast (2019-2026) 11.2 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast by Region (2019-2026) 11.2.1 United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.3 China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.4 Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.5 India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.6 Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.7 Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.2.8 Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) 11.3 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue and Price Forecast by Type (2019-2026) 11.4 Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Forecast by Application (2019-2026) 12 Research Findings and Conclusion 13 Appendix 13.1 Methodology 13.2 Research Data Source

List of Tables and Figures Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Picture Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and CAGR (%) Comparison by Type Table Profile of anticholinergic Table Profile of oral corticosteroid Table Profile of beta2-agonists Table Profile of phosphodiesterase-4 (PDE4) inhibitors Table Profile of others Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption (Sales) Comparison by Application (2014-2026) Table Profile of lung functional test Table Profile of chest x-ray test Table Profile of CT scan Table Profile of others Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Size (Value) and CAGR (%) (2014-2026) Figure United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Germany Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure UK Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure France Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Italy Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Spain Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Russia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Poland Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure China Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure India Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Malaysia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Singapore Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Philippines Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Indonesia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Thailand Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Vietnam Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Brazil Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Mexico Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Colombia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure United Arab Emirates Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Turkey Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Egypt Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure South Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Nigeria Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate (2014-2026) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Status and Outlook (2014-2026) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Player (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Share by Player in 2018 Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Player (2014-2019) Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Player (2014-2019) Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Player (2014-2019) Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Manufacturing Base Distribution and Sales Area by Player Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Product Type by Player Table Mergers & Acquisitions, Expansion Plans Table Gilead Sciences Profile Table Gilead Sciences Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Novartis Profile Table Novartis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Ario Pharma Profile Table Ario Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Mylan Profile Table Mylan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table F. Hoffmann-La Roche Profile Table F. Hoffmann-La Roche Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Asmacure Profile Table Asmacure Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Pearl Therapeutics Profile Table Pearl Therapeutics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Prosonix Profile Table Prosonix Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Merck Profile Table Merck Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Almirall Profile Table Almirall Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Cytokinetics Profile Table Cytokinetics Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table ZAI Lab Profile Table ZAI Lab Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table AstraZeneca Profile Table AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Aquinox Pharmaceuticals Profile Table Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Palobiofarma Profile Table Palobiofarma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Ache Laboratorios Farmaceuticos Profile Table Ache Laboratorios Farmaceuticos Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Invion Profile Table Invion Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Chiesi Farmaceutici Profile Table Chiesi Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Boehringer Ingelheim Profile Table Boehringer Ingelheim Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Pharmaxis Profile Table Pharmaxis Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Innoviva Profile Table Innoviva Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Orion Corporation Profile Table Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table BioMarck Pharmaceuticals Profile Table BioMarck Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Astellas Pharma Profile Table Astellas Pharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table MediciNova Profile Table MediciNova Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Mereo BioPharma Profile Table Mereo BioPharma Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Type (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Type in 2018 Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Type (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Type in 2018 Table Chronic Obstructive Pulmonary Disease (COPD) Drugs Price by Type (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of anticholinergic (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of oral corticosteroid (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of beta2-agonists (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of phosphodiesterase-4 (PDE4) inhibitors (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Growth Rate of others (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Application (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Application (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption of lung functional test (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption of chest x-ray test (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption of CT scan (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption of others (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption by Region (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Consumption Market Share by Region (2014-2019) Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export, Import (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production by Region (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Region (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Region (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Market Share by Region in 2018 Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue by Region (2014-2019) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Region (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Region (2014-2019) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share by Region in 2018 Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Central and South America Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Revenue, Price and Gross Margin (2014-2019) Table Key Raw Materials Introduction of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Market Concentration Rate of Raw Materials Figure Manufacturing Cost Structure Analysis Figure Manufacturing Process Analysis of Chronic Obstructive Pulmonary Disease (COPD) Drugs Figure Chronic Obstructive Pulmonary Disease (COPD) Drugs Industrial Chain Analysis Table Raw Materials Sources of Chronic Obstructive Pulmonary Disease (COPD) Drugs Major Players in 2018 Table Downstream Buyers Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production and Growth Rate Forecast (2019-2026) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue and Growth Rate Forecast (2019-2026) Figure Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price and Trend Forecast (2019-2026) Table United States Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Europe Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table China Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Japan Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table India Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Drugs Production, Consumption, Export and Import Forecast (2019-2026) Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Production Forecast, by Type Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Volume Market Share Forecast, by Type Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Revenue Forecast, by Type Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share Forecast, by Type Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price Forecast, by Type Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Production Forecast, by Application Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Production Volume Market Share Forecast, by Application Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market Revenue Forecast, by Application Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Revenue Market Share Forecast, by Application Table Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Price Forecast, by Application